Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
The order, valued at $18,300, is to be executed within six months, the company said in a regulatory filing.
The contract has been awarded by an international entity and is on a fixed-cost basis. Shelter Pharma added that neither the promoter nor the promoter group has any interest in the entity awarding the order.
The company also clarified that the transaction does not fall under related party transactions.
Shelter Pharma is engaged in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio.
On a full year basis, the company's standalone net profit jumped 16.8% to Rs 7.24 crore on 26.6% rise in net sales to Rs 50.66 crore in FY25 over FY24.
The scrip declined 0.34% to Rs 34.35 on the BSE.
Powered by Capital Market - Live News